🔗 Share this article

This year's Nobel Prize in medical science was awarded for transformative findings that illuminate how the immune system targets dangerous infections while sparing the body's own cells.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this honor.

The research uncovered specialized "sentinels" within the defense system that eliminate rogue defense cells that could attacking the organism.

These findings are now enabling innovative treatments for autoimmune diseases and cancer.

These winners will share a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"Their work has been decisive for comprehending how the body's defenses functions and the reason we do not all suffer from severe autoimmune diseases," stated the head of the award panel.

This team's research explain a core mystery: How does the immune system defend us from numerous infections while keeping our own tissues unharmed?

Our immune system employs immune cells that scan for signs of disease, including pathogens and bacteria it has never encountered.

These cells utilize sensors—known as receptors—that are produced randomly in a vast number of combinations.

This provides the immune system the capacity to combat a wide array of invaders, but the randomness of the mechanism unavoidably creates immune cells that may attack the body.

Security Guards of the Body

Researchers earlier knew that some of these problematic white blood cells were destroyed in the thymus—where white blood cells develop.

This year's Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to neutralize other immune cells that attack the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee added, "These discoveries have laid the foundation for a new field of research and spurred the development of new treatments, for instance for tumors and immune disorders."

In cancer, T-regs block the system from fighting the tumor, so studies are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not being harmed. A comparable method could also be useful in minimizing the risks of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.

He demonstrated that injecting defense cells from healthy animals could stop the disease—implying there was a mechanism for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an inherited immune disorder in rodents and people that led to the discovery of a gene critical for the way regulatory T-cells operate.

"Their groundbreaking research has revealed how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a prominent biological science specialist.

"The work is a striking example of how fundamental biological study can have broad implications for public health."